GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO) » Definitions » Scaled Net Operating Assets

Vicore Pharma Holding AB (OSTO:VICO) Scaled Net Operating Assets : -0.05 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Vicore Pharma Holding AB Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vicore Pharma Holding AB's operating assets for the quarter that ended in Mar. 2024 was kr28.5 Mil. Vicore Pharma Holding AB's operating liabilities for the quarter that ended in Mar. 2024 was kr51.8 Mil. Vicore Pharma Holding AB's Total Assets for the quarter that ended in Dec. 2023 was kr497.8 Mil. Therefore, Vicore Pharma Holding AB's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was -0.05.


Vicore Pharma Holding AB Scaled Net Operating Assets Historical Data

The historical data trend for Vicore Pharma Holding AB's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Scaled Net Operating Assets Chart

Vicore Pharma Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.11 0.03 0.06 -0.08

Vicore Pharma Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.16 0.04 -0.05 -0.05

Competitive Comparison of Vicore Pharma Holding AB's Scaled Net Operating Assets

For the Biotechnology subindustry, Vicore Pharma Holding AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicore Pharma Holding AB's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicore Pharma Holding AB's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Vicore Pharma Holding AB's Scaled Net Operating Assets falls into.



Vicore Pharma Holding AB Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vicore Pharma Holding AB's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(15.179-42.449)/338.007
=-0.08

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=497.838 - 482.659
=15.179

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=42.449 - 0 - 0
=42.449

Vicore Pharma Holding AB's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(28.494-51.829)/497.838
=-0.05

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=540.66 - 512.166
=28.494

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=51.829 - 0 - 0
=51.829

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicore Pharma Holding AB Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicore Pharma Holding AB (OSTO:VICO) Business Description

Traded in Other Exchanges
Address
Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is as a clinical-stage pharmaceutical company focused on severe lung diseases. The group is developing a new type of pharmaceutical compound, known as AT2R agonists, to stimulate the AT2 receptor within the Renin-Angiotensin system. Its drug candidate, C21, is the first small-molecule compound in its class.

Vicore Pharma Holding AB (OSTO:VICO) Headlines

No Headlines